More Medical News
Roche says Herceptin with chemo prolongs survival
5/30/2008

Roche Holding AG's Herceptin, when added
to chemotherapy Xeloda, elongated natural selection without succession




if (lexico_globals.googleafc.ads.content.length)
{
document.write(lexico_globals.googleafc.ads.contenttop);
document.write(lexico_globals.googleafc.ads.sponsoredlinks);
document.write(lexico_globals.googleafc.ads.content[2]);
document.write("");
document.write(lexico_globals.googleafc.ads.contenttop);
document.write(lexico_globals.googleafc.ads.content[3]);
document.write("");
document.write("");
}

roget's ii: the new thesaurusmain entry:advance
part of speech:noun
definition:forward movement.
advancement
of breast cancer by three months compared to chemotherapy
alone, the Swiss drugmaker said on Friday.

More: - From the site

Share |
(Posted in Medical School)
Share and enjoy
  • Digg
  • del.icio.us
  • DZone
  • Netvouz
  • NewsVine
  • Reddit
  • Slashdot
  • StumbleUpon
  • Technorati
  • YahooMyWeb
Post Comment

Notify me of followup comments via e-mail.

Entry 1 of 16100
Last Page | Next Page